Results for tag: "Atrial Fibrillation Drug"

Atrial Fibrillation (AF) is a type of arrhythmia, or irregular heartbeat, that affects the upper chambers of the heart. AF is a common condition, and is the most common type of arrhythmia. AF can cause a variety of symptoms, including palpitations, shortness of breath, and fatigue. Treatment for AF typically involves medications to control the heart rate and rhythm, as well as lifestyle modifications. The Atrial Fibrillation Drug market is a subset of the larger Cardiovascular Drugs market. AF drugs are used to control the heart rate and rhythm, and to reduce the risk of stroke. These drugs are typically anticoagulants, antiarrhythmics, and beta-blockers. AF drugs are used to treat both paroxysmal and persistent AF, and are often used in combination with other treatments. Some companies in the Atrial Fibrillation Drug market include Bristol-Myers Squibb, Pfizer, Sanofi, and Boehringer Ingelheim. Show Less Read more